GC Corp. Stock Korea S.E.

A005257

KR7005252002

Pharmaceuticals

End-of-day quote Korea S.E. 23/09/2026			5-day change	1st Jan Change
18,690.00 ^KRW	+1.08%		+3.83%	-29.07%

08-14	GC Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
06-11	GC Corp.(KOSE:A005250) dropped from KOSPI 200 Index	CI

News in other languages: GC Corp.

31/08/22	Gorbaciov : morto a 91 anni l'ultimo leader dell'Urss (milanofinanza.it)
15/02/22	El Kospi de Corea cae un 1% y amplía sus pérdidas por tercer día -- Market Talk
24/05/21	MÄRKTE ASIEN/Aktien mehrheitlich im Plus - Seoul von Technikwerten gedrückt
01/10/20	Grifols S A : cierra la adquisición de varias plantas en Canadá por 370 millones de dólares
20/07/20	Grifols achète des actifs de plasma à Green Cross pour 460 M$

More news

Managers and Directors: GC Corp.

Manager	Title	Age	Since
Yong-Jun Huh CEO	Chief Executive Officer	52	01/03/2010
Il-Sup Huh CEO	Chief Executive Officer	72	25/03/2010
Yeon-Geun Kim DFI	Director of Finance/CFO	53	-

Director	Title	Age	Since
Il-Sup Huh CHM	Chairman	72	17/12/2010
Yong-Tae Park BRD	Director/Board Member	76	01/03/2009
Yong-Jun Huh BRD	Director/Board Member	52	01/03/2010

More insiders

Green Cross Holdings is a Korea-based holding company principally engaged in the manufacture and distribution of pharmaceuticals. The Company operates its business through five segments. The Pharmaceutical Manufacturing and Sale segment mainly manufactures and sells blood products, general pharmaceuticals, vaccines and over-the-counter (OTC) drugs. The Medical Service and System Development and Supply segment primarily provides healthcare services. The Diagnostic and Analysis segment mainly engages in blood diagnostics and genetic analysis business. The Leasing and Service Business segment is primarily involved in the real estate leasing and the management of affiliated group companies. The Other segment mainly operates livestock operation and other business.

Employees

144

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
23/09/26	₩18,690.00	+1.08%	25
22/09/26	₩18,490.00	+1.37%	11
21/09/26	₩18,240.00	0.00%	108
18/09/26	₩18,240.00	+1.33%	6,539
17/09/26	₩18,000.00	-0.99%	3

End-of-day quote Korea S.E.

More quotes

The best tools reserved for subscribers to boost the performance of your investments!

Market Cap	431B 315M 277M 261M 238M 446M 30.23B 449M 3.13B 1.21B 15.39B 1.18B 1.16B 50.07B	P/E 2024	33.4x	P/E 2025	-10.4x
Enterprise Value	1,825B 1.33B 1.17B 1.11B 1.01B 1.89B 128B 1.9B 13.27B 5.14B 65.13B 5.01B 4.9B 212B	EV / Sales 2024	0.83x	EV / Sales 2025	0.86x
Free-Float	43.96%	Yield 2024	2.89%	Yield 2025	-

08-14	GC Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
06-11	GC Corp.(KOSE:A005250) dropped from KOSPI 200 Index	CI
05-27	Green Cross Holdings to divest 460 billion won worth of stake in Curevo	RE
05-15	GC Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-31	Green Cross Holdings Corporation acquired 22.08% stake in GREEN CROSS WellBeing Corporation from GC Biopharma Corp. for KRW 50.5 billion.	CI
03-18	GC Corp. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
02-11	Green Cross Holdings Corporation announces Annual dividend, payable on April 17, 2026	CI
11-14	Green Cross Holdings Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
14/08/25	Green Cross Holdings Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
19/06/25	Green Cross Holdings Corporation agreed to acquire an additional 23.56% stake in GC Care for KRW 71.9 billion.	CI
15/05/25	Green Cross Holdings Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
18/03/25	Green Cross Holdings Corporation Reports Earnings Results for the Full Year Ended December 31, 2024	CI
14/11/24	Green Cross Holdings Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI

1 day	+1.08%
1 week	+3.83%
Current month	+5.18%
1 month	+2.13%
3 months	+2.69%
6 months	-22.12%
Current year	-29.07%

1 week	17,750	19,610
1 month	16,580	19,610
Current year	13,700	31,700
1 year	13,700	31,700
3 years	13,700	73,900
5 years	13,700	100,000
10 years	12,350	287,000

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
GC CORP.	+1.08%	+3.83%	-	-	316M
ELI LILLY AND COMPANY	+2.68%	+2.56%	+59.32%	+114.68%	1,026B
JOHNSON & JOHNSON	+0.56%	+0.17%	+53.19%	+68.65%	649B
ABBVIE INC.	+0.02%	+0.42%	+20.51%	+73.58%	468B
ROCHE HOLDING AG	+0.06%	+0.61%	+39.82%	+45.71%	352B
NOVARTIS AG	+1.16%	+2.53%	+21.60%	+29.39%	271B
ASTRAZENECA PLC	-0.24%	-0.23%	+10.62%	+12.26%	256B
AMGEN INC.	-0.01%	+6.91%	+45.42%	+51.68%	220B
GILEAD SCIENCES, INC.	-1.11%	-0.80%	+31.69%	+99.56%	188B
NOVO NORDISK A/S	+0.30%	-9.43%	-31.91%	-60.56%	170B
Average	+0.18%	+0.52%	+27.81%	+48.33%	399.9B
Weighted average by Cap.	+0.12%	+1.06%	+38.36%	+67.68%

GC Corp. Stock Korea S.E.

Stocks

A005257

KR7005252002

Pharmaceuticals

Valuation: GC Corp.

Chart: GC Corp.

Latest news: GC Corp.

News in other languages: GC Corp.

Quotes and Performance

Price Extremes

Managers and Directors: GC Corp.

Other Pharmaceuticals

Financials

Company Profile

Quotes

	2024	2025
Net sales	2,205B 1.61B 1.42B 1.34B 1.22B 2.28B 155B 2.3B 16.03B 6.21B 78.68B 6.05B 5.92B 256B	2,451B 1.79B 1.58B 1.48B 1.35B 2.53B 172B 2.55B 17.82B 6.9B 87.48B 6.72B 6.58B 285B
Net income	24.03B 17.55M 15.44M 14.55M 13.28M 24.83M 1.68B 25.02M 175M 67.67M 857M 65.89M 64.46M 2.79B	-69.51B -50.78M -44.66M -42.1M -38.41M -71.84M -4.87B -72.4M -505M -196M -2.48B -191M -187M -8.07B
Net Debt	1,042B 761M 670M 631M 576M 1.08B 73.06B 1.09B 7.57B 2.93B 37.19B 2.86B 2.8B 121B	1,394B 1.02B 896M 844M 770M 1.44B 97.75B 1.45B 10.13B 3.93B 49.75B 3.82B 3.74B 162B